fbpx Yourgene Health plc - Home
003-news.jpg
001-news.jpg
DSC00185r.jpg
002-news.jpg
004-news.jpg
previous arrow
next arrow

The diagnostic testing business has always been dynamic and opportunistic, but nothing could have stretched the definition of these 2 words like a pandemic.

Since the launch of Yourgene Genomic Services 6 months into this global pandemic – born from a legacy, well established NIPT service laboratory, a modest acquisition, and an unprecedented national genomic testing demand, we have vastly expanded our testing capacity by converting every spare inch of underutilised office space created by remote working into high specification diagnostic laboratories capable of handling >15,000 pathogenic samples a day.

Sounds uncomplicated on paper. But what does this journey really look like?

Day 1 – Fascinated and curious. A chapter not one of us has ever experienced before, and as scientists, being at the forefront of understanding and supporting the control of the spread of a disease causing severe social and economic disruption, although unsettling, is captivating.

Month 1 – Moving quickly. Breaking the conventions on how testing regimes are typically launched, we introduce a new service into the market in a matter of weeks.

Month 6 – It’s not going away, lets plan for growth.  Regularly testing hundreds of samples a day, we become skilled in the service provision and take the unique position of being the first laboratory in the UK to offer SARS-CoV-2 PCR testing with our own CE-marked product and plan for growth. Knocking down walls, hiring more talent and investing in automation to build an efficient operation to cater for 1000+ samples a day, equating to a larger daily capacity than a laboratory of our size at the time would receive in months.

Another lockdown. Not anticipated, COVID-19 spreads like wildfire and the UK moves into 4 to 5 months of tiered to complete isolation. The DHSC and UKAS provide governance and structure for the hundreds of laboratories offering COVID-19 testing services in the UK steering our efforts into compliance, audits and various due diligence hurdles from the government never seen before. We adapt to the rapidly evolving and new regulatory requirements for PCR testing. Soon to follow, alarming new variants of the virus arise and a national request for genome sequencing services calls. As one of the handful of laboratories in the UK with Next Generation Sequencing capability (a complex genetic technology) we step up to the challenge, this time launching the service in just a matter of days!! Remembering only 6 months ago launching a much simpler service within weeks was uncharacteristic. 

Yet uncertain at every month where our place is in the market, we wait.

Year 1 – Preparing for something, but what? A year into the pandemic with almost half spent in isolation the UK looks to open international doors. Let’s prepare the laboratory, but what are we preparing for? Numerous executive discussions and options are proposed, and we take what we believe is the most opportunistic yet de-risked approach to supply the demand by holding our capacity while poising ourselves for growth if the demand arrives.

Summer #2 – Madness! The UK borders fully open up and the world demands safety in PCR testing and new variant surveillance. Now rubber stamped as an ISO15189 Medical Laboratory and Service Provider we offer an assured service to airports, pharmacies, clinics and retailers. At peak we receive over 15,000 samples a day!! 15,000 samples a day! That’s more tests received in a normal year in one day. Mind-blowing.

Each day calls for a transformative decision, out-of-box ideas arise several times a day during our now 24 hours a day, 7 days a week operation. Innovation becomes an hourly mantra. We knock down more walls. We reconfigure our laboratories. For those of you that have never worked in a laboratory, changes take weeks of design, months of construction, followed by weeks to months of validation. We do this 5 times…in 8 weeks!

We use robotics never used in the genomics testing space. Weeks later we start to work with the manufacturer to adapt their novel robotics to provide further customised capabilities.

A community of talent grows, the team - a jump from 15 to 75 staff - becomes a family, seeing people unlock potential they never even knew they had. And we see this daily.

By the Autumn this becomes our conventional way of working. Ultra-dynamic and exceptionally opportunistic becomes the new norm in diagnostic services.

  • Behind the scenes: Adapting diagnostic services during a pandemic - 11 November 2021 +

    The diagnostic testing business has always been dynamic and opportunistic , but nothing could have stretched the definition of these 2 words like a pandemic.

    Since the launch of Yourgene Genomic Services 6 months into this global pandemic – born from a legacy, well established NIPT service laboratory, a modest acquisition, and an unprecedented national genomic testing demand, we have vastly expanded our testing capacity by converting every spare inch of underutilised office space created by remote

    Read More
  • Overprescribing within the NHS - 02 November 2021 +

    “Good for you, good for us but is it good for everybody?”
    Overprescribing within the NHS – October 2021


    The NHS is currently the 5th largest global employer; with over 1.3m employees and receiving around 10% of the UK Government’s annual spending. It is estimated that the NHS deals with 336 million ‘patient visits’ per year, - many of whom will receive some form of at least one ‘prescription’ per visit and at a current charge in

    Read More
  • The role genomics plays in relationships - 18 August 2021 +

    According to National Today, the website dedicated to highlighting every day celebrations and holidays, August 18 th is ‘National Couple’s Day’ – a day to celebrate the important relationships in life. Whilst not an official holiday or observance in any country, the clinical team at Yourgene Health wanted to use this opportunity to reflect upon the pivotal role that genomics plays in relationships across the world.

    Earlier this year a study, published in Nature Human Behaviour,

    Read More
  • NIPT for Sex Chromosome Aneuploidies and Autosomal Aneuploidies. A Q&A with Dr Greg Fitzgibbon - 26 May 2021 +

    Yourgene Health has recently launched IONA ® Care , an advanced prenatal screening test that performs whole-genome analysis to measure the likelihood that a pregnant woman is carrying a fetus with one the most common trisomies (trisomy 21, 18 and 13), any other Autosomal Aneuploidy (AA) or a Sex Chromosome Aneuploidy (SCA). IONA ® Care is available from the Yourgene Genomic Services laboratory in Manchester, UK. The test is available as a menu, enabling pregnant women, their families

    Read More
  • COVID-19 testing and the need for regulation - 6 May 2021 +

    The COVID-19 pandemic presented huge challenges worldwide. In response to the unprecedented need for COVID-19 PCR testing, the UK government set up a new network of Lighthouse laboratories across the country to provide the required capacity for testing thousands of samples each day. These laboratories proved a vital part of the test and trace strategy but were also under immense pressure to meet their targets and, following an investigation by Panorama , it was found that

    Read More
  • Yourgene on World Creativity and Innovation Day 2021 - 21 April 2021 +

    Innovation and creativity are two pillars at the heart of technological and scientific advances. The instrumental role they play has been recognised by the United Nations (UNN), who have designated a special day to raise awareness of the importance of innovation in culture and economic growth worldwide: 21st April. World Creativity and Innovation Day (UNN) is a day to encourage people to “think outside the box”, find new perspectives which push personal growth, identify different

    Read More
  • The IONA® test recommended for twin pregnancies screening for Down’s syndrome - 7 April 2021 +

    In recent years, fertility treatments and the fact women are having babies later has made multiple births more common. In 2016, around 12,000 sets of twins and about 190 sets of triplets or more were born in the UK. That means about 1 in every 65 births in the UK today are twins, triplets or more. 1 Extensive studies have been carried out for cell-free DNA (cfDNA) testing in singleton pregnancies with sample numbers into

    Read More
  • Blood clots, inherited thrombophilia and COVID-19 - 25 March 2021 +

    Recent reports in the media from a collection of European countries suggest that there may be cause for concern with regards to the Oxford AstraZeneca COVID-19 vaccine and abnormal blood clotting. According to Norway’s medicines agency (NoMA), four new cases of “serious blood clotting in adults” have been identified following a recent review (1). Austria have suspended the use of one particular batch of the vaccine after two events, including an individual diagnosed with multiple

    Read More
  • COVID-19 strains - what are they and why do they matter? A Q&A with Dr Michael Risley - 28 January 2021 +

    The COVID-19 pandemic, also known as the coronavirus pandemic, is an ongoing pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Since the beginning of the global COVID-19 outbreak, the diagnostic and research community has undertaken an unprecedented effort to understand how best to manage, eradicate and prevent the disease. In recent months we have seen the rollout of ambitious vaccination schedules worldwide, as well as the strengthening of

    Read More
  • So much to be proud of! - 23 December 2020 +

    As many have already said and written, this year has been like none other. This has been especially true for conferences and exhibitions. Every year, the commercial team at Yourgene look forward to exhibiting at various conferences globally. It’s a chance to meet our partners and customers, as well as form new relationships. With the COVID-19 pandemic none of this was possible, so when we heard that the Taiwan Healthcare Expo was still going ahead,

    Read More
  • COVID-19 vaccines and the continued role of testing - 16 November 2020 +

    Last week we had the great news that a safe and effective vaccine against SARS-CoV-2 should soon be available. Thanks to the work of Pfizer and  BioNTech , we may have the opportunity to start vaccinating those at highest risk of severe disease towards the end of this year  and into 2021.  The interim analysis of their clinical trial has indicated that it is more than 90% effective in preventing COVID - 19 in participants who haven’t

    Read More
  • The role of DPYD testing in managing a successful response to the COVID-19 pandemic - 5 November 2020 +

    Since the beginning of the global COVID-19 outbreak, the diagnostic and research community has undertaken an unprecedented effort to understand how best to manage, eradicate and prevent the disease. Two key pillars in the fight against the pandemic are establishing a robust testing strategy and implementing procedures and processes to reduce the burden on healthcare systems.  

    Independent SAGE recently published a document containing core recommendations for how best to optimize and develop the current testing

    Read More
  • 1